Healthcare -
Biotechnology - NASDAQ - US
$ 7.675
-2.23 %
$ 407 M
Market Cap
-3.69
P/E
STOK - OPERATING INCOME
Operating Income STOK - Stoke Therapeutics, Inc.
-115 M
LAST VALUE
-15.48%
2 YEAR CAGR
-55.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR